Novovax Inc has developed and launched Estrasorb, a transdermally absorbed, micro-encapsulated estradiol, as an estrogen replacement therapy for short-term use in the reduction of vasomotor symptoms in menopausal women. Estrasorb was launched in the US in April 2004.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Estrasorb.
IDrugs
September 2004
University of Bari, Department of Obstetrics and Gynecology, Corso Alcide de Gasperi 495, 70125 Bari, Italy.
Novovax Inc has developed and launched Estrasorb, a transdermally absorbed, micro-encapsulated estradiol, as an estrogen replacement therapy for short-term use in the reduction of vasomotor symptoms in menopausal women. Estrasorb was launched in the US in April 2004.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!